Frailty in Older Adults with Cancer - Medical Oncology Department The Christie NHS Foundation Trust Manchester, UK | Springer Nature Switzerland AG | 2022 - 494 Pages

This book summarizes evidence on frailty and ageing, how this may impact patient outcomes and how frailty can be assessed, managed and incorporated in the decision-making process for older patients with cancer. The book aims to: empower clinical teams to assess and support older cancer patients with frailty, ideally within a multidisciplinary setting; and to improve the selection of older cancer patients to the most appropriate management/treatment strategies in order to improve the outcomes of this group of patients often underrepresented in research.

The reader will learn the methods available for assessing frailty, such as screening tools, but also how to perform different geriatric assessments covering the different key components (physical, nutritional, social, psychological, etc.). The book also provides information on how to manage and intervene on frailty with the role of pre-habilitation and re-habilitation, how to set-up specialised teams and pathways within one’s hospital and community for these older cancer patients with frailty. Finally, the management of this challenging group of patients according to the cancer type is discussed in detail, alongside with mapping the unmet research needs and future directions in this field.

ISBN: 978-3-030-89161-9 978-3-030-89162-6 (eBook) = adjuvant adults with cancer adults with frailty Ann Oncol associated benefit bevacizumab breast cancer cachexia cancer treatment capecitabine carboplatin carcinoma CGA chemotherapy Clin Oncol clinical practice clinical trials cognitive impairment cohort colorectal cancer comorbidity comprehensive geriatric assessment decision-making diagnosis disease docetaxel dose drug ECOG elderly patients endometrial cancer Engl factors frailty in older G gemcitabine Geriatr Oncol geriatric assessment geriatric oncology guidelines https://doi identify impact improve increased interventions lung cancer melanoma ment metastatic Mohile mortality multidisciplinary muscle nivolumab non-small-cell lung cancer NSCLC nutritional older adults older cancer patients older patients Oncologist outcomes ovarian cancer overall survival oxaliplatin palliative palliative care patients aged patients with advanced patients with cancer patients with frailty performance status phase polypharmacy postoperative predict prehab prognostic prostate cancer radiotherapy randomised randomized resection risk sarcopenia screening tools SIOG Society of Geriatric surgery surgical symptoms systematic review therapy toxicity trastuzumab tumour versus

Subjects--Personal Names: --Cancer, Geriatrics, Internal medicine, Medical / Clinical Medicine, Medical / Geriatrics, Medical / Internal Medicine, Medical / Oncology / General, Medical / Pain Management, Medical / Surgery / General, Medical / Terminal Care, Oncology, Palliative treatment, Surgery, Frail older people, Geriatric oncology -- Decision making.